Group One Trading’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,322
Closed -$38K 5731
2018
Q4
$38K Sell
1,322
-200
-13% -$5.68K ﹤0.01% 3699
2018
Q3
$42K Buy
+1,522
New +$42.8K ﹤0.01% 4076
2018
Q1
Sell
-734
Closed -$17.9K 5609
2017
Q4
$18K Sell
734
-1,840
-71% -$48.5K ﹤0.01% 4196
2017
Q3
$71K Sell
2,574
-7,889
-75% -$210K ﹤0.01% 3446
2017
Q2
$262K Buy
10,463
+10,271
+5,349% +$254K ﹤0.01% 2445
2017
Q1
$5K Sell
192
-283
-60% -$7.82K ﹤0.01% 4310
2016
Q4
$12K Sell
475
-1,875
-80% -$46.4K ﹤0.01% 3901
2016
Q3
$59K Buy
2,350
+1,975
+527% +$46K ﹤0.01% 3260
2016
Q2
$8K Buy
+375
New +$6.69K ﹤0.01% 4159
2015
Q4
Sell
-31,195
Closed -$492K 5353
2015
Q3
$492K Buy
31,195
+6,365
+26% +$102K 0.01% 1798
2015
Q2
$355K Buy
24,830
+24,085
+3,233% +$408K 0.01% 2082
2015
Q1
$13K Sell
745
-4,788
-87% -$84.6K ﹤0.01% 4069
2014
Q4
$99K Buy
+5,533
New +$89.1K ﹤0.01% 2853
2014
Q3
Sell
-2,863
Closed -$38.6K 5639
2014
Q2
$41K Buy
+2,863
New +$37.4K ﹤0.01% 3678
2014
Q1
Sell
-1,181
Closed -$15.4K 5788
2013
Q4
$12K Buy
1,181
+500
+73% +$5.67K ﹤0.01% 4524
2013
Q3
$9K Buy
+681
New +$8.93K ﹤0.01% 4542

Other funds holding NXTM

Group One Trading's NXTM Position: Q1 2019 in Review

Group One Trading sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,322 shares — an estimated $38K sold.

Group One Trading first reported a position in NXTM in Q3 2013 and held it in 16 quarters. The position peaked at $492K in Q3 2015. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Group One Trading reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Group One Trading sold 1,322 NxStage Medical Inc. shares in Q1 2019, an estimated $38K.
  • Group One Trading first reported a position in NxStage Medical Inc. in Q3 2013 and held it in 16 quarters.
  • Group One Trading's NxStage Medical Inc. position peaked at $492K in Q3 2015.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.